HIV diagnoses in France declined between 2013 and 2018, corresponding with introduction of universal ART provision in 2013 and large-scale PrEP rollout in 2016.
Updated analysis of 2016 continuum of HIV care found that 11 mostly Western European countries are on track to meet UNAIDS 90-90-90 goal
Community viremia and HIV incidence both significantly decreased from 2012-2017 among gay and bisexual men in Australia.
Low prevalence of transmitted ARV resistance and clinically relevant resistance to recommended first-line ARVs observed in cohort of ART-naive PWH in Spain.
Analysis of the EuResist database reveals prevalence and predictors of resistance to all 4 main ARV drug classes in treatment-experienced patients in Europe.
Reduced inpatient and outpatient visits observed following SVR with oral HCV DAA therapy in real-world HIV/HCV-coinfected population.
HCV incidence in MSM with HIV in France declined from 2014 to 2017 following unrestricted access of HCV DAA therapy for persons with HIV.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.